Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Type 1 Cardiorenal Syndrome.
Daniel T IlgesMorgan L DermodyCaitlyn BlankenshipValerie MansfieldJoseph S Van TuylPublished in: Journal of cardiovascular pharmacology and therapeutics (2021)
In patients with type 1 CRS, AW was not associated with improved renal function at 72 hours. A larger sample size is necessary to confirm these results.